FIELD: medicine.
SUBSTANCE: composition containing nanoparticles comprising taxane and albumin is administered in the patient who previously received gemcitabine as a first-line anticancer therapy and showed a positive response to this treatment. Administering the composition accompanied the gemcitabine therapy.
EFFECT: specified combined administration of the preparations as a second-line therapy of pancreatic cancer provides the more effective treatment of this disease.
24 cl, 4 dwg, 7 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR COMBINATION THERAPY OF PROLIFERATIVE DISEASES | 2011 |
|
RU2577278C2 |
| COMBINED THERAPY WITH COMPOSITIONS OF TAXANE NANOPARTICLES AND HEDGEHOG INHIBITORS | 2010 |
|
RU2561055C2 |
| COMBINATION AND METHODS FOR INTRODUCING THERAPEUTIC AGENTS AND COMBINED THERAPY | 2006 |
|
RU2452482C2 |
| COMBINATIONS AND METHODS FOR ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY | 2013 |
|
RU2673805C2 |
| ANTITUMOR AGENT, ANTITUMOR ENHANCER AND ANTITUMOR KIT | 2017 |
|
RU2752172C2 |
| COMBINATIONS AND METHODS FOR THERAPEUTIC AGENTS INTRODUCTION AND COMBINED THERAPY | 2012 |
|
RU2632103C2 |
| COMPOSITIONS WITH PACLITAXEL, ALBUMIN AND BINDING AGENT AND METHODS FOR THEIR USE AND PREPARATION | 2017 |
|
RU2756892C2 |
| METHOD OF TREATING OPERABLE PANCREATIC HEAD ADENOCARCINOMA | 2019 |
|
RU2706347C1 |
| METHOD OF TREATING INOPERABLE PANCREATIC HEAD ADENOCARCINOMA | 2019 |
|
RU2706341C1 |
| METHOD OF TREATING OPERABLE PANCREATIC HEAD ADENOCARCINOMA | 2019 |
|
RU2706339C1 |
